ArticleNPJ precision oncology2022

Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer.

Omar Elakad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.